Search

CRBSI in long-term and acute care wards – Full Text

CLABSI

“This study examined differences in nosocomial-onset urinary tract-related bloodstream infections (UTRBSIs) and catheter-related bloodstream infections (CRBSIs) between patients admitted to long-term and acute care wards” Kumagai et al (2025).

Studying CRBSI with skin-like replicas – Full Text

CLABSI

“In IV therapy simulations, we observed bacterial growth dynamics over the incubation period. Our findings suggest that Ecoflex-based skin-like replicas can serve as a valuable tool for developing and testing new catheters, while the potential for use in other medical innovation devices, including wearable sensing devices, ultimately contributes to improved patient outcomes and infection control strategies” Althumayri et al (2025).

Preventing PICC complications

picc

“Ultrasound-guided catheter insertion and nonsilicone catheters effectively prevented PICC complications. The evidence for other comparisons was too uncertain to draw conclusions, highlighting the urgent need for additional studies on prevention and control interventions” Dobrescu et al (2025).

CRBSI among hemodialysis patients – Full Text

CLABSI

“Over 50% of patients developed CRBSI and gram-positive bacteria were the major causative bacteria. Associated factors were multifactorial and preventive care would be ideal to reduce the number of CRBSI based on these findings” Costantine et al (2025).

Drug resistance and CRBSI

clabsi

“We analyzed the clinical distribution and the antibiotic susceptibility of pathogens for catheter-related blood stream infection (CRBSI) in the hospital retrospectively” Sun et al (2024).

Factors associated with CRBSI mortality – Full Text

CLABSI

“Enhanced monitoring of factors, such as candida detected in blood culture, CRBSI onset within 30 days of catheter insertion, concurrent infection, low serum albumin level, elevated C-reactive protein (CRP) level and the use of a peripherally inserted central catheter (PICC), is crucial for mitigating CRBSI severity and risk of death” Futamura et al (2024).

CLABSI rates in Colombia 2015-2018 – Full Text

CLABSI

“Central line-associated bloodstream infections (CLABSIs) are a significant healthcare challenge globally, increasing mortality risk and complicating central vascular catheter use. In Colombia, few studies have assessed the impact of CLABSIs on hospital stay and mortality” Mosquera et al (2024).

CRBSI in hemodialysis patients – Full Text

CLABSI

“The incidence of CRBSI was found to be 0.78 episodes per 1,000 catheter-days. Acute hemodialysis catheter type and anemia were associated with increased risk for CRBSI, with a P-value less than 0.05” Bitunguramye et al (2024).

COVID-19 infection and risk of candidaemia

clabsi

“Patients in ICUs with COVID-19 infections have a much higher risk of candidaemia, CLAC and its associated mortality. Network level data helps in understanding the true burden of candidaemia and will help in framing infection control policies for the country” Mathur et al (2024).

Catheter-related candidemia in non-ICU patients – Full Text

CLABSI

“During the COVID-19 pandemic, Candida spp. was a notable cause of CRBSIs in our center, underscoring the importance of considering Candida spp. in suspected CRBSI cases, including those in non-ICU settings and in those with PVADs” Scaglione et al (2024).

CRBSI treatment case study – Full Text

CLABSI

“We present a case of an immunocompetent pediatric patient with severe hemophilia B and M. cosmeticum CRBSI. While the patient’s hemophilia B precluded a standard line holiday, he successfully cleared his infection with two line exchanges followed by two weeks of antibiotics” Turock et al (2024).

Catheter-related septic thrombosis treatment – Full Text

CLABSI

“A recent study showed that a short course of antimicrobial therapy (≤3 weeks) had similar outcomes to a prolonged course on CRBSI-ST. From this perspective, starting from the desirable goal of shortening the treatment duration, we discuss how the path to the correct diagnosis and management of CRBSI-ST may be paved with several challenges” Maraolo et al (2024).

Device-associated nosocomial infections in intensive care units

CLABSI

“Antibiotic resistance of the Gram-negative bacteria associated with invasive device-associated infections increased during the study period. Antimicrobial stewardship will reduce rates of nosocomial infections, reduce mortality, and shorten hospital stay” Mert et al (2024).

Long-term dialysis catheter-associated Agromyces mediolanus bacteremia

clabsi

“Human infections caused by Agromyces mediolanus are rare; it has been reported twice, and both cases were associated with prolonged use of catheters, not only parenteral catheter but also peritoneal catheter, which is of special importance for patients with end-stage renal disease (ESRD)” Haq et al (2023).

CLABSI rates among hemodialysis patients – Full Text

CLABSI

“In conclusion, the incidence of catheter-related bloodstream infection among patients on hemodialysis was high with gram-negative predominance. Early fistula must be planned to reduce the duration of temporary vascular access” Weldetensae et al (2023).

Central catheter care in hemodialysis patients

clabsi

“In our dialysis unit in Shenzhen Guangdong Province China, we have developed and used our own dialysis catheter care protocol since May 2013 with good results. In this study, we would like to share our experience with the other units” Mai et al (2024).

CLABSI management qualitative study – Full Text

CLABSI

“Management practices such as timely analysis of HAIs, collaboration between facility leadership and multidisciplinary team members, and a focus on identifying the failure of a procedure or protocol, rather than the failure of staff members, are all approaches that can support infection prevention efforts” Gaughan et al (2024).

CLABSI rates in trauma patients

clabsi

“This study aimed to identify the rate of positive (+)CLABSI in trauma patients and risk factors associated with (+)CLABSI” Aryan et al (2024).

Home CLABSI rate decreased by 52%

clabsi

“The ambulatory CLABSI rate decreased by 52% from 0.25 to 0.12 per 1000 CL days post intervention, achieved within 27 months; 117 CLABSI were prevented, with $4.2 million hospital charges and 702 hospital days avoided” Wong et al (2024).

Register for free citation alerts

Supporting your vascular access and infusion therapy learning journey